Androgen receptor gene polymorphisms and risk for androgenetic alopecia: A meta-analysis

Clinical and Experimental Dermatology

Volumn 37, Issue 2, 2012, Pages 104-111

  Zhuo, F L ^a   Xu, W ^a   Wang, L ^a   Wu, Y ^b   Xu, Z L ^a   Zhao, J Y ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA EXTRACTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EMBASE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE TYPE ALOPECIA; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; RISK;

ALOPECIA; GENE FREQUENCY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RISK FACTORS;

EID: 84857369476     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04186.x     Document Type: Article

References (30)

1. Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 2010; 162: 843-7.
2. Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001; 27: 53-4. (Pubitemid 32107618)
3. Khumalo NP, Jessop S, Gumedze F, et al. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol 2007; 157: 981-8. (Pubitemid 47583500)
4. Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 2001; 145: 95-9.
5. Tang PH, Chia HP, Cheong LL, et al. A community study of male androgenetic alopecia in Bishan, Singapore. Singapore Med J 2000; 41: 202-5.
6. Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol 2007; 143: 1401-6. (Pubitemid 350146267)
7. Xu F, Sheng YY, Mu ZL, et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 2009; 160: 629-32.
8. Levy-Nissenbaum E, Bar-Natan M, Frydman M, et al. Confirmation of the association between male pattern baldness and the androgen receptor gene. Eur J Dermatol 2005; 15: 339-40. (Pubitemid 41337408)
9. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002; 37: 981-90.
10. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 2003; 26: 76-83. (Pubitemid 36408236)
11. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 2002; 16: 2181-7. (Pubitemid 35155532)
12. Ellis JA, Scurrah KJ, Cobb JE, et al. Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 2007; 121: 451-7. (Pubitemid 46554681)
13. Brown CJ, Goss SJ, Lubahn DB, et al. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 1989; 44: 264-9. (Pubitemid 19045022)
14. Gottlieb B, Beitel LK, Wu JH, et al. The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 2004; 23: 527-33. (Pubitemid 38720602)
15. Nelson KA, Witte JS. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 2002; 155: 883-90. (Pubitemid 34517843)
16. Ding D, Xu L, Menon M, et al. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 2005; 62: 133-9. (Pubitemid 40096779)
17. Lu J, Danielsen M. A StuI polymorphism in the human androgen receptor gene (AR). Clin Genet 1996; 49: 323-4. (Pubitemid 26297332)
18. Gong M, Long J, Liu Q, et al. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010; 325: 78-83.
19. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18: 805-35. (Pubitemid 350295185)
20. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005; 28: 123-37.
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58. (Pubitemid 34746062)
22. Viechtbauer W. Confidence intervals for the amount of heterogeneity in meta-analysis. Stat Med 2007; 26: 37-52. (Pubitemid 46099416)
23. Peters JL, Sutton AJ, Jones DR, et al. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676-80. (Pubitemid 43209069)
24. Hayes VM, Severi G, Eggleton SA, et al. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005; 14: 993-6. (Pubitemid 40478569)
25. Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 2005; 77: 140-8. (Pubitemid 40848045)
26. Zhao YP, Tu P, Yang SY, et al. The relationship of androgen receptor CAG polymorphism and male pattern baldness. Chin J Derm Venereol 2007; 21: 654-6.
27. Prodi DA, Pirastu N, Maninchedda G, et al. EDA2R is associated with androgenetic alopecia. J Invest Dermatol 2008; 128: 2268-70.
28. El-Samahy MH, Shaheen MA, Saddik DE, et al. Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia. Int J Dermatol 2009; 48: 584-7.
29. Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 1998; 110: 849-53. (Pubitemid 28237687)
30. Nyholt DR, Gillespie NA, Heath AC, et al. Genetic basis of male pattern baldness. J Invest Dermatol 2003; 121: 1561-4. (Pubitemid 38005516)